Clinical Trial Update: Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating safety and immunogenicity of different sequential schedules of bOPV and IPV for poliomyelitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• IPV (Inactivated poliovirus vaccine)
• bOPV (bivalent oral polio vaccine)

Snippet

Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED